{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:40:09Z","timestamp":1750488009880,"version":"3.41.0"},"reference-count":21,"publisher":"Jaypee Brothers Medical Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.59556\/japi.72.0668","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:20:11Z","timestamp":1750486811000},"page":"11-13","source":"Crossref","is-referenced-by-count":0,"title":["The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy"],"prefix":"10.59556","volume":"72","author":[{"given":"Nihar","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Samat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20250621062007_B1","doi-asserted-by":"crossref","first-page":"1791\u2013","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction.","volume":"372:","author":"Bonaca","year":"2015;","journal-title":"N Engl J Med"},{"key":"key20250621062007_B2","doi-asserted-by":"crossref","first-page":"2487\u2013","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.","volume":"397:","author":"Koo","year":"2021;","journal-title":"Lancet"},{"key":"key20250621062007_B3","doi-asserted-by":"crossref","first-page":"1329\u2013","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).","volume":"348:","author":"CAPRIE Steering Committee.","year":"1996;","journal-title":"Lancet"},{"key":"key20250621062007_B4","doi-asserted-by":"crossref","first-page":"552\u2013","DOI":"10.1111\/j.1538-7836.2010.04160.x","article-title":"In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.","volume":"9:","author":"Armstrong","year":"2011;","journal-title":"J Thromb Haemost"},{"key":"key20250621062007_B5","doi-asserted-by":"crossref","first-page":"273\u2013","DOI":"10.1111\/jth.13216","article-title":"Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.","volume":"14:","author":"Traby","year":"2016;","journal-title":"J Thromb Haemost"},{"key":"key20250621062007_B6","doi-asserted-by":"crossref","first-page":"1082\u2013","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease.","volume":"68:","author":"Levine","year":"2016;","journal-title":"J Am Coll Cardiol"},{"key":"key20250621062007_B7","doi-asserted-by":"crossref","first-page":"213\u2013","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"39:","author":"Valgimigli","year":"2018;","journal-title":"Eur Heart J"},{"key":"key20250621062007_B8","doi-asserted-by":"crossref","first-page":"2414\u2013","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial.","volume":"321:","author":"Watanabe","year":"2019;","journal-title":"JAMA"},{"key":"key20250621062007_B9","doi-asserted-by":"crossref","first-page":"2496\u2013","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"65:","author":"Palmerini","year":"2015;","journal-title":"J Am Coll Cardiol"},{"key":"key20250621062007_B10","doi-asserted-by":"crossref","first-page":"n1332.","DOI":"10.1136\/bmj.n1332","article-title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.","volume":"373:","author":"Valgimigli","year":"2021;","journal-title":"BMJ"},{"key":"key20250621062007_B11","doi-asserted-by":"crossref","first-page":"e21\u2013","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization.","volume":"79:","author":"Lawton","year":"2022;","journal-title":"J Am Coll Cardiol"},{"key":"key20250621062007_B12","doi-asserted-by":"crossref","first-page":"e028775.","DOI":"10.1161\/JAHA.122.028775","article-title":"Dual-antiplatelet therapy after percutaneous coronary intervention: how short is too short?","volume":"12:","author":"Mourikis","year":"2023;","journal-title":"J Am Heart Assoc"},{"key":"key20250621062007_B13","doi-asserted-by":"crossref","first-page":"1274\u2013","DOI":"10.1016\/S0140-6736(18)30493-8","article-title":"6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.","volume":"391:","author":"Hahn","year":"2018;","journal-title":"Lancet"},{"key":"key20250621062007_B14","doi-asserted-by":"crossref","first-page":"e027055.","DOI":"10.1161\/JAHA.122.027055","article-title":"Long-term outcomes and duration of dual antiplatelet therapy after coronary intervention with second-generation drug-eluting stents: the veterans affairs extended DAPT study.","volume":"12:","author":"Kinlay","year":"2023;","journal-title":"J Am Heart Assoc"},{"issue":"(42):","key":"key20250621062007_B15","doi-asserted-by":"crossref","first-page":"e31158.","DOI":"10.1097\/MD.0000000000031158","article-title":"Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: a network meta-analysis.","volume":"101","author":"Luo","year":"2022;","journal-title":"Medicine (Baltimore)"},{"key":"key20250621062007_B16","doi-asserted-by":"crossref","first-page":"1425\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis.","volume":"142:","author":"Khan","year":"2020;","journal-title":"Circulation"},{"key":"key20250621062007_B17","doi-asserted-by":"crossref","first-page":"954\u2013","DOI":"10.1093\/eurheartj\/ehac706","article-title":"Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.","volume":"44:","author":"Costa","year":"2023;","journal-title":"Eur Heart J"},{"issue":"(2):","key":"key20250621062007_B18","doi-asserted-by":"crossref","first-page":"108\u2013","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study.","volume":"147","author":"Kang","year":"2023;","journal-title":"Circulation"},{"key":"key20250621062007_B19","doi-asserted-by":"crossref","first-page":"2443\u2013","DOI":"10.1016\/S0140-6736(21)01120-X","article-title":"Antiplatelet therapy for secondary prevention of cardio- vascular disease: challenging the certainties.","volume":"397:","author":"Chiarito","year":"2021;","journal-title":"Lancet"},{"issue":"(2):","key":"key20250621062007_B20","doi-asserted-by":"crossref","first-page":"87\u2013","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019;","journal-title":"Eur Heart J"},{"key":"key20250621062007_B21","doi-asserted-by":"crossref","first-page":"e008530.","DOI":"10.1161\/CIRCINTERVENTIONS.119.008530","article-title":"Clinical usefulness of PRECISE-DAPT score for predicting bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an analysis from the SMART-DATE randomized trial.","volume":"13:","author":"Choi","year":"2020;","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:20:14Z","timestamp":1750486814000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-72-11-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.59556\/japi.72.0668"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0668","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}